Lisa Hammond, M.D.

Concepts (303)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Dacarbazine	4	2004	552	0.390	Why?
Neoplasms	44	2008	22350	0.380	Why?
Camptothecin	9	2007	599	0.360	Why?
Antineoplastic Agents	23	2007	13650	0.350	Why?
Antineoplastic Agents, Phytogenic	11	2008	617	0.330	Why?
Quinazolines	6	2006	1369	0.320	Why?
HLA-B Antigens	3	2003	330	0.290	Why?
Oligopeptides	4	2006	1195	0.280	Why?
Antineoplastic Agents, Alkylating	5	2004	614	0.280	Why?
Antineoplastic Combined Chemotherapy Protocols	14	2007	11872	0.270	Why?
Dose-Response Relationship, Drug	34	2006	10748	0.260	Why?
Depsipeptides	2	2006	95	0.260	Why?
Rifabutin	1	2004	53	0.230	Why?
Carmustine	1	2004	137	0.230	Why?
Immunogenetics	1	2003	62	0.220	Why?
Maximum Tolerated Dose	16	2008	896	0.220	Why?
Molecular Probe Techniques	1	2004	111	0.220	Why?
Area Under Curve	14	2006	1639	0.210	Why?
Neutropenia	10	2006	892	0.190	Why?
Topotecan	2	2000	131	0.190	Why?
Infusions, Intravenous	15	2008	2227	0.180	Why?
Tomography, Emission-Computed	1	2003	1007	0.180	Why?
Carbamates	1	2001	191	0.170	Why?
Drug Design	1	2003	1045	0.150	Why?
Topoisomerase II Inhibitors	1	1998	94	0.150	Why?
Topoisomerase I Inhibitors	1	1998	70	0.150	Why?
Receptor Protein-Tyrosine Kinases	2	2004	1621	0.140	Why?
Sesquiterpenes	3	2004	175	0.140	Why?
Etoposide	1	1998	639	0.130	Why?
Paclitaxel	7	2006	1728	0.130	Why?
Benzimidazoles	1	2001	862	0.130	Why?
Thionucleotides	2	2005	107	0.120	Why?
Guanine	2	2007	280	0.120	Why?
Maytansine	2	2008	88	0.120	Why?
Glutamates	2	2007	384	0.120	Why?
Drug Administration Schedule	15	2006	4855	0.120	Why?
Administration, Oral	10	2004	4026	0.110	Why?
Cholestanols	2	2003	8	0.110	Why?
Enzyme Inhibitors	5	2004	3726	0.110	Why?
Aminoglycosides	2	2005	161	0.100	Why?
Antimetabolites, Antineoplastic	4	2006	645	0.100	Why?
Cisplatin	3	2005	1656	0.100	Why?
HLA-A Antigens	2	2003	223	0.100	Why?
Oligonucleotides, Antisense	2	2005	462	0.100	Why?
Genes, p53	2	2006	711	0.090	Why?
Half-Life	5	2008	648	0.090	Why?
Drug Interactions	6	2007	1419	0.090	Why?
Hematologic Diseases	6	2008	498	0.090	Why?
Diagnostic Imaging	1	2004	3530	0.090	Why?
Metabolic Clearance Rate	4	2006	361	0.080	Why?
Angiogenesis Inhibitors	4	2006	2055	0.080	Why?
Taxoids	2	2004	665	0.080	Why?
Aged	48	2008	171319	0.080	Why?
Prodrugs	2	2002	274	0.080	Why?
Medical Records	1	2014	1409	0.080	Why?
Drug Resistance, Multiple	2	2001	255	0.080	Why?
Middle Aged	51	2014	223233	0.080	Why?
Positron-Emission Tomography	1	2004	6550	0.070	Why?
Adult	49	2008	223317	0.070	Why?
Nausea	7	2006	682	0.070	Why?
Venous Thrombosis	2	2014	1321	0.070	Why?
Indoles	2	2006	1836	0.070	Why?
Pyridines	3	2004	2890	0.070	Why?
Apoptosis	2	2001	9513	0.060	Why?
Models, Chemical	5	2005	607	0.060	Why?
Oncogene Proteins v-erbB	1	2004	17	0.060	Why?
Male	50	2008	364203	0.060	Why?
Bibenzyls	1	2004	11	0.060	Why?
Oxonic Acid	1	2004	32	0.060	Why?
Tegafur	1	2004	40	0.060	Why?
Tetracyclines	1	2004	64	0.060	Why?
Physiological Phenomena	1	2004	18	0.060	Why?
Adenoviruses, Human	1	2006	257	0.060	Why?
Aged, 80 and over	16	2006	59548	0.060	Why?
Decision Support Techniques	1	2014	2006	0.060	Why?
Heterocyclic Compounds, 1-Ring	1	2004	68	0.060	Why?
Wales	1	2003	87	0.060	Why?
Guideline Adherence	1	2014	2232	0.060	Why?
Humans	64	2014	767040	0.060	Why?
Female	50	2008	396660	0.060	Why?
Lung Neoplasms	4	2004	13491	0.060	Why?
Benzoquinones	1	2004	198	0.050	Why?
Sterols	1	2003	63	0.050	Why?
Alkyl and Aryl Transferases	1	2003	89	0.050	Why?
Stilbenes	1	2004	155	0.050	Why?
Radioligand Assay	1	2003	365	0.050	Why?
O(6)-Methylguanine-DNA Methyltransferase	1	2003	82	0.050	Why?
Neoplasm Metastasis	4	2006	4892	0.050	Why?
Adenosylmethionine Decarboxylase	1	2002	11	0.050	Why?
Mucin-1	2	2004	536	0.050	Why?
Lactates	1	2003	398	0.050	Why?
Lactams, Macrocyclic	1	2004	319	0.050	Why?
Gene Frequency	3	2003	3621	0.050	Why?
Dioxolanes	1	2002	23	0.050	Why?
Sulfonylurea Compounds	1	2003	220	0.050	Why?
Isotope Labeling	1	2003	390	0.050	Why?
Polyamines	1	2002	132	0.050	Why?
Time Factors	12	2006	40154	0.050	Why?
Deoxycytidine	2	2003	886	0.050	Why?
Cytomegalovirus	1	2006	751	0.050	Why?
Butyrates	1	2002	164	0.050	Why?
Phthalazines	1	2004	397	0.050	Why?
Morpholines	1	2004	584	0.050	Why?
HSP90 Heat-Shock Proteins	1	2004	422	0.050	Why?
Venous Thromboembolism	1	2014	1883	0.050	Why?
Leukemia, Experimental	1	2001	224	0.050	Why?
Thalidomide	1	2006	886	0.040	Why?
Urea	1	2003	448	0.040	Why?
Receptors, Vascular Endothelial Growth Factor	1	2004	661	0.040	Why?
Pulmonary Embolism	1	2014	2598	0.040	Why?
Cytosine	1	2002	213	0.040	Why?
Antibodies, Monoclonal	4	2004	9245	0.040	Why?
Diarrhea	5	2006	1319	0.040	Why?
Quinolones	1	2003	389	0.040	Why?
Tissue Distribution	1	2004	2275	0.040	Why?
Pyrroles	1	2006	1122	0.040	Why?
Colorectal Neoplasms	3	2005	6966	0.040	Why?
Uridine	1	2000	135	0.040	Why?
Pyrazolones	1	1999	8	0.040	Why?
Anthraquinones	1	1999	41	0.040	Why?
Organic Chemicals	1	2000	211	0.040	Why?
Genetics, Population	1	2003	943	0.040	Why?
Drug Screening Assays, Antitumor	1	2001	719	0.040	Why?
Thrombocytopenia	5	2006	1172	0.040	Why?
Metalloendopeptidases	1	2000	386	0.040	Why?
Retinal Diseases	1	2004	709	0.040	Why?
Growth Inhibitors	1	1999	375	0.040	Why?
Melanoma, Experimental	1	2001	557	0.040	Why?
Proto-Oncogene Proteins c-bcl-2	1	2004	1405	0.040	Why?
Liver Diseases	1	2006	1304	0.040	Why?
Isoxazoles	1	1999	233	0.040	Why?
Clinical Trials as Topic	2	2003	8048	0.040	Why?
Leukocytes, Mononuclear	4	2005	1854	0.040	Why?
Melanoma	2	2006	5702	0.040	Why?
Polyethylene Glycols	1	2003	1188	0.030	Why?
Vomiting	4	2000	655	0.030	Why?
Neoplasm Transplantation	1	2000	2012	0.030	Why?
Down-Regulation	1	2004	2931	0.030	Why?
Europe	1	2003	3432	0.030	Why?
Corticotropin-Releasing Hormone	1	1998	362	0.030	Why?
Sequence Analysis, DNA	2	2003	4780	0.030	Why?
Carcinoma, Non-Small-Cell Lung	2	2004	5389	0.030	Why?
ATP-Binding Cassette Transporters	1	1998	566	0.030	Why?
Salvage Therapy	1	2002	1271	0.030	Why?
Fluorouracil	1	2000	1652	0.030	Why?
Protein Kinase Inhibitors	3	2006	5693	0.030	Why?
Mice, Nude	1	2000	3618	0.030	Why?
Cell Division	1	2001	4473	0.030	Why?
Skin	2	2006	4499	0.030	Why?
Radiopharmaceuticals	1	2003	2702	0.030	Why?
Receptor, erbB-2	1	2004	2599	0.030	Why?
Tumor Cells, Cultured	1	2001	6106	0.030	Why?
Brain Edema	1	1998	601	0.030	Why?
Carcinoma	1	2004	2326	0.030	Why?
Blood Platelets	1	2004	2464	0.030	Why?
Retina	1	2004	2659	0.030	Why?
Kidney Failure, Chronic	1	2006	2495	0.030	Why?
DNA	2	2006	7210	0.030	Why?
Medical Audit	1	2014	454	0.030	Why?
Cell Cycle	1	2001	2927	0.030	Why?
Leukemia	1	2001	1518	0.030	Why?
Transplantation, Heterologous	1	2000	2391	0.020	Why?
Heparin, Low-Molecular-Weight	1	2014	344	0.020	Why?
Carboplatin	2	2006	790	0.020	Why?
Follow-Up Studies	5	2006	39317	0.020	Why?
Pyrimidines	1	2004	3044	0.020	Why?
Carbazoles	2	2005	230	0.020	Why?
Protein Binding	1	2004	9327	0.020	Why?
Animals	5	2004	168965	0.020	Why?
Neutrophils	1	2004	3779	0.020	Why?
Statistics, Nonparametric	3	2002	2850	0.020	Why?
Biopsy	2	2004	6777	0.020	Why?
Tumor Suppressor Protein p53	1	2001	2952	0.020	Why?
Dexamethasone	1	1998	1963	0.020	Why?
Drug Resistance, Neoplasm	2	2004	5332	0.020	Why?
Piperidines	1	1998	1667	0.020	Why?
Antineoplastic Agents, Hormonal	1	1998	1536	0.020	Why?
Neoplasm Proteins	1	2001	3599	0.020	Why?
Glucosides	2	2005	533	0.020	Why?
Drug Combinations	2	2005	2086	0.020	Why?
Immunohistochemistry	4	2004	11063	0.020	Why?
Drug Eruptions	2	2002	335	0.020	Why?
Pyrazoles	1	1999	2028	0.020	Why?
Fatigue	2	2006	1556	0.020	Why?
Adenocarcinoma	1	2004	6360	0.020	Why?
Asthenia	1	2006	16	0.020	Why?
Chromatography, High Pressure Liquid	2	2001	1531	0.020	Why?
Mice	3	2004	81912	0.020	Why?
Immunosuppressive Agents	1	1998	4210	0.020	Why?
Partial Thromboplastin Time	1	2006	203	0.020	Why?
Tomography, X-Ray Computed	2	2005	20741	0.020	Why?
Orotate Phosphoribosyltransferase	1	2004	5	0.010	Why?
Liver Function Tests	1	2006	526	0.010	Why?
Neoplasm Staging	3	2006	11217	0.010	Why?
Bilirubin	1	2006	440	0.010	Why?
Treatment Outcome	7	2006	65295	0.010	Why?
Ovarian Neoplasms	1	2001	4903	0.010	Why?
Farnesyltranstransferase	1	2003	71	0.010	Why?
Inhibitory Concentration 50	1	2004	464	0.010	Why?
Protein Prenylation	1	2003	70	0.010	Why?
Intercalating Agents	1	2003	33	0.010	Why?
Tablets	1	2003	149	0.010	Why?
Lymphopenia	1	2005	300	0.010	Why?
Benzofurans	1	2003	139	0.010	Why?
HLA-B27 Antigen	1	2002	66	0.010	Why?
Patient Selection	2	2006	4256	0.010	Why?
Vitamin B 12	1	2006	529	0.010	Why?
Amidines	1	2002	28	0.010	Why?
Anti-Bacterial Agents	1	2001	7469	0.010	Why?
Edema	1	2006	764	0.010	Why?
Molecular Structure	1	2006	1882	0.010	Why?
Matrix Metalloproteinases	1	2004	391	0.010	Why?
Electroretinography	1	2004	524	0.010	Why?
Indans	1	2002	92	0.010	Why?
Prostatic Neoplasms	1	2004	11097	0.010	Why?
Evoked Potentials, Visual	1	2004	417	0.010	Why?
Survival Analysis	2	2004	10092	0.010	Why?
Stereoisomerism	1	2002	612	0.010	Why?
Pilot Projects	1	2014	8732	0.010	Why?
Enzyme-Linked Immunosorbent Assay	1	2008	3804	0.010	Why?
Biological Availability	1	2001	387	0.010	Why?
Phenylurea Compounds	1	2003	531	0.010	Why?
Pleural Effusion	1	2003	344	0.010	Why?
Peripheral Nervous System Diseases	1	2006	716	0.010	Why?
Antibody Formation	1	2004	1392	0.010	Why?
Blood Coagulation	1	2006	1163	0.010	Why?
Tissue Inhibitor of Metalloproteinase-2	1	2000	71	0.010	Why?
Exanthema	1	2004	502	0.010	Why?
Phenylbutyrates	1	2000	72	0.010	Why?
Mutation	1	2004	30211	0.010	Why?
Solubility	1	2001	1078	0.010	Why?
Cytoprotection	1	2000	199	0.010	Why?
Tyrosine	1	2003	1425	0.010	Why?
Folic Acid	1	2006	1336	0.010	Why?
Granulocyte Colony-Stimulating Factor	1	2001	631	0.010	Why?
Magnetic Resonance Imaging	2	2004	36582	0.010	Why?
Receptors, Platelet-Derived Growth Factor	1	1999	178	0.010	Why?
Immunity, Cellular	1	2004	1560	0.010	Why?
Anticoagulants	1	2014	4854	0.010	Why?
Vitamins	1	2007	1639	0.010	Why?
Mitogen-Activated Protein Kinases	1	2003	1244	0.010	Why?
Cell Adhesion Molecules	1	2004	1612	0.010	Why?
Acetates	1	2000	314	0.010	Why?
ras Proteins	1	2003	1054	0.010	Why?
Multidrug Resistance-Associated Proteins	1	1998	105	0.010	Why?
Headache	1	2006	1261	0.010	Why?
Protein Structure, Tertiary	1	2004	3760	0.010	Why?
Matrix Metalloproteinase 2	1	2000	461	0.010	Why?
Safety	1	2002	1157	0.010	Why?
Breast Neoplasms	2	2004	21178	0.010	Why?
Visual Fields	1	2004	1063	0.010	Why?
Feasibility Studies	2	1999	5311	0.010	Why?
Practice Guidelines as Topic	1	2014	7435	0.010	Why?
Kinetics	1	2004	6287	0.010	Why?
Haplotypes	1	2003	2722	0.010	Why?
Antigens, Neoplasm	1	2004	1997	0.010	Why?
Drug Synergism	1	2000	1759	0.010	Why?
Matrix Metalloproteinase 9	1	2000	633	0.010	Why?
Genetic Vectors	1	2006	3402	0.010	Why?
Brain Neoplasms	1	1998	9108	0.010	Why?
Structure-Activity Relationship	1	2002	3052	0.010	Why?
Adrenalectomy	1	1998	347	0.010	Why?
Quinolines	1	2000	770	0.010	Why?
Adrenal Glands	1	1998	557	0.010	Why?
Vascular Endothelial Growth Factor A	1	2006	3511	0.010	Why?
Immunoconjugates	1	2003	975	0.010	Why?
Anemia	1	2004	1514	0.010	Why?
Pyrazines	1	2000	1204	0.010	Why?
Tumor Necrosis Factor-alpha	1	2006	4349	0.010	Why?
Promoter Regions, Genetic	1	2006	5796	0.010	Why?
Prostate-Specific Antigen	1	2004	2463	0.010	Why?
Biphenyl Compounds	1	2000	1026	0.010	Why?
Antibodies, Viral	1	2006	3212	0.010	Why?
Antibodies	1	2002	2419	0.010	Why?
Hospitalization	1	2014	10815	0.010	Why?
Up-Regulation	1	2003	4143	0.010	Why?
Stomach Neoplasms	1	2004	1481	0.010	Why?
Body Weight	1	2004	4627	0.010	Why?
Cell Differentiation	2	2002	11657	0.010	Why?
Dietary Supplements	1	2007	3446	0.010	Why?
Gastrointestinal Diseases	1	2002	1205	0.010	Why?
Phosphorylation	1	2004	8310	0.010	Why?
Disease-Free Survival	1	2003	6844	0.010	Why?
Protein-Tyrosine Kinases	1	2002	2428	0.010	Why?
Risk Assessment	1	2014	24299	0.010	Why?
Analysis of Variance	1	2001	6215	0.010	Why?
Cohort Studies	2	2007	41718	0.010	Why?
Regression Analysis	1	2002	6331	0.010	Why?
Base Sequence	1	2002	12414	0.010	Why?
Amino Acid Sequence	1	2002	13411	0.010	Why?
Bone Marrow	1	2001	2926	0.010	Why?
Molecular Sequence Data	1	2002	17608	0.010	Why?
Kidney Diseases	1	2000	2099	0.010	Why?
Hydrocortisone	1	1998	1840	0.010	Why?
RNA, Messenger	1	2004	12793	0.010	Why?
Disease Progression	1	2006	13646	0.010	Why?
Signal Transduction	2	2003	23621	0.000	Why?
Image Processing, Computer-Assisted	1	2004	8940	0.000	Why?
Liver	1	2003	7578	0.000	Why?
Double-Blind Method	1	1998	12451	0.000	Why?
Survival Rate	1	1998	12823	0.000	Why?
Adolescent	1	2003	89046	0.000	Why?
Heart Failure	1	1999	11877	0.000	Why?

Hammond's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (303)

Explore

Co-Authors (4)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors